A Drug Repurposing Screen Identifies Fludarabine Phosphate as a Potential Therapeutic Agent for N-MYC Overexpressing Neuroendocrine Prostate Cancers

Neuroendocrine prostate cancer (NEPC) represents a highly aggressive form of prostate tumors. NEPC results from trans-differentiated castration-resistant prostate cancer (CRPC) with increasing evidence indicating that the incidence of NEPC often results from the adaptive response to androgen depriva...

Descripción completa

Detalles Bibliográficos
Autores principales: Elhasasna, Hussain, Khan, Raymond, Bhanumathy, Kalpana K., Vizeacoumar, Frederick S., Walke, Prachi, Bautista, Maricris, Dahiya, Dinesh K., Maranda, Vincent, Patel, Hardikkumar, Balagopal, Amrutha, Alli, Nezeka, Krishnan, Anand, Freywald, Andrew, Vizeacoumar, Franco J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317991/
https://www.ncbi.nlm.nih.gov/pubmed/35883689
http://dx.doi.org/10.3390/cells11142246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317991/
https://www.ncbi.nlm.nih.gov/pubmed/35883689
http://dx.doi.org/10.3390/cells11142246

Ejemplares similares